您的位置: 首页 > 农业专利 > 详情页

Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
专利权人:
AstraZeneca AB
发明人:
McKerrecher, Darren,Pike, Kurt Gordon,Waring, Michael James
申请号:
AU2010235903
公开号:
AU2010235903B2
申请日:
2010.10.19
申请国别(地区):
AU
年份:
2012
代理人:
摘要:
#$%^&*AU2010235903B220120705.pdf#####C NRPonbMI)CCVJ)AR 1241294_ .DOC-15/10/2010 ABSTRACT R- 0 5 Compounds of formula (1) wherein R', HET-l and HIET-2 are as described in the specification, and their salts and pro-drugs, are activators of glucokinase (GLK) and are thereby useful in the treatment of, for example, type 2 diabetes. Processes for preparing 10 compounds of formula (I) are also described.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充